ReviewIndian journal of gastroenterology : official journal of the Indian Society of Gastroenterology2026
Technical considerations in endoscopic ultrasound-guided liver biopsy: A comprehensive review.
Review in Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Liver biopsy continues to serve as a cornerstone in the evaluation of diffuse and unexplained liver disease, yet the percutaneous and trans-jugular routes are limited by safety concerns, patient acceptability and sampling variability. Endoscopic ultrasound-guided liver biopsy (EUS-LB) has emerged as a safe and effective alternative, offering real-time access to both lobes and the opportunity to combine tissue acquisition with other endoscopic interventions. This review summarizes current evidence on EUS-LB, with focus on technical considerations including needle design, gauge, number of passes and actuations, suction techniques and specimen handling. Reported diagnostic adequacy consistently meets or exceeds established histologic benchmarks, while adverse event rates are comparable to percutaneous and trans-jugular biopsy. Bleeding is the most notable complication, though it is uncommon and usually self-limiting. Beyond tissue acquisition, the concept of EUS as a "one-stop" platform-integrating biopsy, portal pressure gradient measurement, elastography and therapeutic interventions is gaining importance. With ongoing refinements and accumulating supportive data, EUS-LB is increasingly recognized as a versatile, minimally invasive and comprehensive tool in hepatology.
Indexed as
Identifiers
41546822What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.